On April 3, 2024, Gelonghui Pharmaceutical-B (02142.HK) announced that on April 3, 2024, according to the share option plan and share award plan separately adopted by the company's shareholders on November 23, 2020, the company granted 8.310,000 share options and 3.105 million share awards to eligible participants, subject to acceptance by the grantor.
和铂医药-B(02142.HK)授出830.8万份购股权及310.5万份股份奖励
Hebo Pharmaceutical-B (02142.HK) grants 8.38,000 share options and 3.105 million share awards
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.